Skip to content
Open access

Elunetirom, a brain-targeted TRβ prodrug, promotes neuronal plasticity and mitochondrial biogenesis-related signaling in primary neuronal cultures

Jul 2026 · bioRxiv · 0 citations · 35 references
Biology

TL;DR

It is indicated that elunetirom and LL- 340001 engage complementary neuroplasticity and mitochondrial biogenesis-related programs in neuronal systems and support further investigation of brain-targeted thyromimetic signaling as a mechanistically differentiated approach for major depressive disorder and bipolar depression.

Read PDF

Similar papers

Open access Aug 2026

PT320, a GLP-1 receptor agonist, mitigates nucleus accumbens–associated depression- and anxiety-like behaviors in MitoPark mice of Parkinson's disease

By restoring neurotrophic signaling and dopaminergic function, PT320 represents a promising therapeutic strategy for PD-related anxiety and depression by restoring neurotrophic signaling and dopaminergic function in the nucleus accumbens.

Kuan-Yin Tseng, Tung-Tai Kuo, P. Chang et al. · 0 citations
Review Open access Aug 2026

Reprogramming brain bioenergetics in depression: an integrative framework linking creatine, branched-chain amino acids, and exercise to neuroplasticity, cognitive function, and depression-related outcomes

This integrative paradigm highlights the potential of creatine supplementation, BCAAs, and physical exercise to support depression-related outcomes through distinct yet complementary mechanisms involving bioenergetic regulation, enhanced exercise capacity, neuroplastic adaptations, and improved cognitive and emotional...

Xiaoqin Xu, Li Liu · 0 citations
Open access Sep 2026

Trace Amine-Associated Receptors (TAARs) as Emerging Targets in Neuropsychiatric Disorders

Mechanistically, TAAR1 agonists differ in their effects on dopamine transporter function and monoaminergic neuron activity, indicating that their pharmacological effects are compound-specific rather than class-wide, which distinguish TAAR1-targeting compounds from classical D2 receptor antagonists and may underlie thei...

Antonello Pinna, Charles Prendergast, A. Pałasz · 0 citations
Review Sep 2026

From Structural Resolution to Functional Elucidation: Research Progress of GPR158 as a Target for Antidepressant Drug Development.

Findings in this review reveal the potential regulatory function of GPR158 in the pathological process of depression and provide a solid theoretical basis for the development of antidepressant drugs targeting GPCRs, facilitating the subsequent development of more accurate and efficient antidepressant candidate drugs.

Wei Guan, Ya-Bin Zheng · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.